2-104855815-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM2PP2BP4

The NM_006236.3(POU3F3):​c.305C>T​(p.Pro102Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 29)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

POU3F3
NM_006236.3 missense

Scores

3
5
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.18

Publications

0 publications found
Variant links:
Genes affected
POU3F3 (HGNC:9216): (POU class 3 homeobox 3) This gene encodes a POU-domain containing protein that functions as a transcription factor. The encoded protein recognizes an octamer sequence in the DNA of target genes. This protein may play a role in development of the nervous system. [provided by RefSeq, Apr 2015]
PANTR1 (HGNC:49513): (POU3F3 adjacent non-coding transcript 1) Predicted to act upstream of or within regulation of gene expression. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 12 curated pathogenic missense variants (we use a threshold of 10). The gene has 2 curated benign missense variants. Gene score misZ: 3.0416 (below the threshold of 3.09). Trascript score misZ: -0.11043 (below the threshold of 3.09). GenCC associations: The gene is linked to snijders blok-fisher syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.37211442).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POU3F3NM_006236.3 linkc.305C>T p.Pro102Leu missense_variant Exon 1 of 1 ENST00000361360.4 NP_006227.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POU3F3ENST00000361360.4 linkc.305C>T p.Pro102Leu missense_variant Exon 1 of 1 6 NM_006236.3 ENSP00000355001.2

Frequencies

GnomAD3 genomes
Cov.:
29
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1041100
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
509578
African (AFR)
AF:
0.00
AC:
0
AN:
19668
American (AMR)
AF:
0.00
AC:
0
AN:
11012
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
11886
East Asian (EAS)
AF:
0.00
AC:
0
AN:
14510
South Asian (SAS)
AF:
0.00
AC:
0
AN:
42186
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
15398
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2954
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
886734
Other (OTH)
AF:
0.00
AC:
0
AN:
36752
GnomAD4 genome
Cov.:
29

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jan 30, 2020
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The alteration results in an amino acid change:_x000D_ _x000D_ The c.305C>T (p.P102L) alteration is located in coding exon 1 of the POU3F3 gene. This alteration results from a C to T substitution at nucleotide position 305, causing the proline (P) at amino acid position 102 to be replaced by a leucine (L). The alteration is not observed in population databases: _x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the POU3F3 c.305C>T alteration was not observed, with coverage at this position. The altered amino acid is conserved throughout evolution:_x000D_ _x000D_ The p.P102 amino acid is somewhat conserved in available vertebrate species on limited sequence alignment. The alteration is predicted tolerated by in silico modeling:_x000D_ _x000D_ The p.P102L alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Benign
-0.0091
T
BayesDel_noAF
Benign
-0.25
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Benign
0.21
T
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.43
FATHMM_MKL
Benign
0.45
N
LIST_S2
Uncertain
0.88
D
M_CAP
Pathogenic
0.46
D
MetaRNN
Benign
0.37
T
MetaSVM
Uncertain
-0.14
T
MutationAssessor
Benign
1.1
L
PhyloP100
3.2
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
-1.6
N
REVEL
Uncertain
0.30
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0050
D
Polyphen
0.99
D
Vest4
0.24
MutPred
0.38
Loss of glycosylation at P102 (P = 0.0214);
MVP
0.75
ClinPred
0.79
D
GERP RS
0.57
Varity_R
0.16
gMVP
0.31
Mutation Taster
=63/37
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1553426334; hg19: chr2-105472273; API